REVEALED: Bngo | Vintage Vibes

Why BioNano Genomics (BNGO) Stock Is Getting Hammered Tuesday

BioNano Genomics Inc (NASDAQ:BNGO) shares are trading sharply lower in Tuesday’s session after the company announced the pricing of a $10 million public offering.

Benzinga · Sep 16, 2025

Bionano Genomics (BNGO) Challengers: 3 Biotech Innovators to Buy Instead

With the rising aging population and the emergence of new diseases, the biotech industry appears poised for steady growth. Therefore, three quality biotech stocks, Vanda Pharmaceuticals (VNDA), Organogenesis Holdings (ORGO), and Exelixis (EXEL), could be better catches than Bionano Genomics (BNGO). Read on….

StockNews.com · Sep 22, 2023

Bionano Genomics (BNGO) vs. Gilead Sciences (GILD): Buy, Hold or Sell these Biotech Stocks?

As the biotech industry reaches new heights with innovation and the accessibility of big data, let us analyze whether biotech stocks Bionano Genomics and Gilead Sciences are a Buy, Hold, or Sell.

StockNews.com · Sep 18, 2023

Is Bionano Genomics (BNGO) a Buy or Sell this Week?

Genomic testing devices manufacturer Bionano Genomics (BNGO) is witnessing steady revenue growth. However, unfortunately, it did not translate into a bottom-line improvement. Moreover, as BNGO faces the possibility of delisting, is it worth buying now? Keep reading.

StockNews.com · Jun 16, 2023

Is Now the Time to Buy Bionano Genomics (BNGO)?

Biotech company Bionano Genomics (BNGO) has significant topline growth under its belt. However, its bottom line outlook is concerning. Would it be wise to invest in the stock now? Let’s look at some of its financial metrics to find out….

StockNews.com · Jun 1, 2023

Calling All Quality Control: Get Rid of These 3 Biotech Stocks ASAP!

High-interest rates are expected to impact the growth of the biotech industry. Therefore, fundamentally weak biotech stocks Bionano Genomics (BNGO), VBI Vaccines (VBIV), and 180 Life Sciences (ATNF) might be best avoided now. Read on….

StockNews.com · Mar 29, 2023

The 3 Hottest Biotech Stocks to Own in 2023 and 1 to Avoid

Biotech companies are on track to stay resilient amid a potential economic slowdown due to their inelastic demand and continued breakthroughs. Therefore, it could be wise to invest in fundamentally strong biotech stocks Gilead Sciences (GILD), United Therapeutics (UTHR), and Jazz Pharmaceuticals (JAZZ). On the other hand, Bionano Genomics (BNGO)…

StockNews.com · Feb 16, 2023

2 Biotech Stocks to Buy and 1 to Avoid Like the Plague

The biotech industry is expected to witness solid growth driven by growing government initiatives and increasing demand across several sectors. While we think fundamentally sound biotech stocks Gilead Sciences (GILD) and United Therapeutics (UTHR) could be solid buys this year, Bionano Genomics (BNGO) could be best avoided considering its fundamental…

StockNews.com · Jan 19, 2023

Is This Biotech Stock a Buy for Under $3?

Biotech company Bionano Genomics (BNGO) has beaten analysts’ top-line estimate in the third quarter. However, its cash and cash equivalents balance has declined year-over-year. Therefore, is it a buy now under $3? Read on to find out….

StockNews.com · Nov 23, 2022

1 Biotech Stock You Shouldn't Follow Wall Street's Bullishness On

Wall Street analysts expect Biotech stock Bionano Genomics (BNGO) to grow more than 160% in the near term. However, the stock’s fundamentals appear bleak, and the stock has lost more than 20% in 2022. Therefore, investors might avoid following Wall Street’s bullishness on this stock. Let’s find out….

StockNews.com · Nov 7, 2022